Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.

F. Moosig, E. Reinhold-Keller, E. Csernok, W. L. Gross

5 Citations (Scopus)
Original languageEnglish
JournalArthritis and Rheumatism
Issue number3
Pages (from-to)566-567
Number of pages2
Publication statusPublished - 03.1998

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this